Combined Epidermal Growth Factor Receptor and Beclin1 Autophagic Protein Expression Analysis Identifies Different Clinical Presentations, Responses to Chemo- and Radiotherapy, and Prognosis in Glioblastoma

Dysregulated EGFR in glioblastoma may inactivate the key autophagy protein Beclin1. Each of high EGFR and low Beclin1 protein expression, independently, has been associated with tumor progression and poor prognosis. High (H) compared to low (L) expression of EGFR and Beclin1 is here correlated with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biomed Res Int
Päätekijät: Tini, Paolo, Belmonte, Giuseppe, Toscano, Marzia, Miracco, Clelia, Palumbo, Silvia, Pastina, Pierpaolo, Battaglia, Giuseppe, Nardone, Valerio, Butorano, Marie Aimée Gloria Munezero, Masucci, Armando, Cerase, Alfonso, Pirtoli, Luigi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2015
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363549/
https://ncbi.nlm.nih.gov/pubmed/25821789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/208076
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia